Tic Disorders in Childhood
Overview
Pediatrics
Authors
Affiliations
Despite our familiarity with tic disorders, their management remains challenging. The difficulty seldom relates to the diagnosis, which is usually based on the history, but rather in dealing with the impact of the tics and multiple comorbidities. The child and family must be educated and must be taught how to facilitate a positive attitude among others who come in contact with the patient. Knowledge and acceptance of the tics by other family members, peers, teachers, and coaches often become central to the child's well-being. Although many children can be managed without pharmacotherapy, medications are often central to achieving success. The goals of therapy and the appropriate choice of medication must be individualized. We are frequently challenged not only by the wide array of medication choices available but also by the decision of which symptom to treat first. The tics, despite being flamboyant, are often viewed by the child and family as less disabling than co-occurring conditions, such as attention-deficit hyperactivity disorder, obsessive-compulsiveness, or rage. Even when tics are the major issue, patients must define their goals for therapy. It is unreasonable to expect a complete resolution of tics and safety usually rules in favor of better tolerated but potentially less efficacious therapies. Developing strategies to minimize the lifelong impact of the multiple components of Tourette syndrome is an essential aspect of the care of these patients.
We've all been wrong about provisional tic disorder.
Grossen S, Arbuckle A, Bihun E, Koller J, Song D, Reiersen A Compr Psychiatry. 2024; 134:152510.
PMID: 38941871 PMC: 11373539. DOI: 10.1016/j.comppsych.2024.152510.
Marino C, Khan K, Groom M, Hall S, Anderson S, McNally E BMC Health Serv Res. 2023; 23(1):788.
PMID: 37488511 PMC: 10367334. DOI: 10.1186/s12913-023-09753-5.
Mohammadi M, Badrfam R, Khaleghi A, Ahmadi N, Hooshyari Z, Zandifar A Child Psychiatry Hum Dev. 2021; 53(5):1036-1046.
PMID: 33966152 DOI: 10.1007/s10578-021-01186-7.
The New Tics study: A Novel Approach to Pathophysiology and Cause of Tic Disorders.
Black K, Kim S, Schlaggar B, Greene D J Psychiatr Brain Sci. 2020; 5.
PMID: 32587895 PMC: 7316401. DOI: 10.20900/jpbs.20200012.
Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report.
Okazaki K, Yamamuro K, Iida J, Kishimoto T Ann Gen Psychiatry. 2019; 18:2.
PMID: 30899317 PMC: 6410501. DOI: 10.1186/s12991-019-0226-6.